What Researchers Did
Researchers conducted a retrospective study of 140 CO poisoning patients admitted to an ICU at a university hospital in Taiwan from 2001 to 2010, analyzing factors predicting mortality and the impact of HBOT.
What They Found
Overall ICU mortality was 14.3%. Independent predictors of death were APACHE II score above 25, Glasgow Coma Scale of 3, and more than 3 organ dysfunctions on admission. Multivariate analysis found that receiving HBOT significantly reduced the risk of death in ICU CO poisoning patients.
What This Means for Canadian Patients
This large ICU study strongly supports HBOT for severe CO poisoning. For Canadian ICU teams, this study provides evidence that HBOT should be prioritized for the sickest CO poisoning patients -- those with coma, multi-organ failure, and high APACHE II scores -- rather than reserved for mild cases only.
Canadian Relevance
Carbon monoxide poisoning is an OHIP-covered indication for HBOT in Ontario.
Study Limitations
This was a retrospective single-center study from Taiwan; ICU practices, patient demographics, and HBOT availability differ from Canadian settings.